期刊文献+

BimS慢病毒RNA干扰载体的构建及其感染效率和干扰效果的实验研究 被引量:1

Construction and the infection efficiency of BimS lentivirus RNA interference vector
下载PDF
导出
摘要 目的:应用RNA干扰技术构建BimS慢病毒RNA干扰载体,探讨其感染效率和干扰效果。方法:针对人BimS设计3个干扰靶点,将单链引物退火成双链oligo序列,连接入AgeI和EcoRI双酶切线性化载体中。将重组质粒进行病毒包装、并且通过感染ACC-2细胞观察其感染效率,定量PCR检测其对BimS mRNA干扰效果。结果:PCR产物经扩增电泳后阳性克隆得到337bp条带,插入序列片段与DNA测序结果完全相符。重组慢病毒载体在293T细胞中包装获得滴度为2×10~8 TU/ml的病毒颗粒,MOI=20,转染效率为85%。转染pFU-GV-BmS-1组、pFU-GV-BmS-2组及对照组BmS mRNA相对表达水平分别为:0.743±0.025、0.466±0.023、1.266±0.042(组间两两比较,P<0.05)。结论:BimS慢病毒RNA干扰载体构建成功,并能高效感染ACC-2细胞及下调BmS mRNA表达。 Objective: To construct BimS lentivirus RNA interference(RNAi) vector and to study its infection efficiency by using RNAi technique. Methods: Three interference targets were designed according to the BimS sequence. The single chain primer was an- nealed into double-stranded oligo sequences, and tilen connected with vector linearized with Age I and EcoR I enzyme. The recombi- nant plasmid was packaged, and the infection efficiency was observed by infecting ACC-2 cells. Results: After amplification, a 337 bp band was appeared in the electrophoresis results of positive clones. Sequence of inserted fragments were identical with the result of DNA sequencing. Restructuring lentivirus was packed in 293T cells, the virus titer was 2 ~ l0s TU/ml, MOI = 20, and the transtbction efficiency was 85%. The BmS mRNA relative expression of pFU-GV-BINS-1, pFU-GV-BMS-2 and control group was 0. 743 ± 0. 025, 0. 466 ± 0. 023 and 1. 266 ± 0. 042 respectively( between each 2 groups, P 〈 0.05 ). Conclusion : BimS lentivirus virus RNA interfer- ence vectors can be constructed, and can efficiently infect ACC-2 cells.
作者 姚佳 饶国洲 李旭奎 YAO Jia RAO Guozhou LI Xukui(710004, Department of Oral and Maxillofacial Surgery, Stomalogical Hospital of Medical College , Xi'an Jiaotong University, China)
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2017年第1期36-40,共5页 Journal of Practical Stomatology
基金 陕西省社发攻关资助项目(编号:2013k12-03-21)
关键词 RNA干扰 BimS基因 慢病毒表达载体 RNA interference BimS gene Lentivirus vector
  • 相关文献

参考文献3

二级参考文献35

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin, 2013, 63(1): 11-30. 被引量:1
  • 2Tsuchiya S, Okuno Y, Tsujimoto G. MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer. J Pharmacol Sci, 2006, 101 (4): 267-270. 被引量:1
  • 3Yan L-X, Huang X-F, Shao Qz et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 2008, 14(11): 2348-2360. 被引量:1
  • 4Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med, 2005, 3.53(17): 1768-1771. 被引量:1
  • 5Fujita Y Kojima K, Hamada N, et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun, 2008, 377( 1 ): 114-119. 被引量:1
  • 6Hamano R, Miyata H, Yamasaki M, et al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated throughactivation of the akt signaling pathway. Clin Cancer Res, 2011, 17(9): 3029-3038. 被引量:1
  • 7Luzna P, Gregar J, Uberall I, et al. Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol, 2011, 6:114. 被引量:1
  • 8Pichiorri Fj Suh S-S, Rocci A et al. Downregulation of pS3-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell, 2010, 18(4): 367-381. 被引量:1
  • 9Jin Z, Selaru FM, Cheng Y, et al. MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene, 2011, 30(13): 1577-1585. 被引量:1
  • 10Feng S, Cong S, Zhang X, et al. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer ceils. Nucleic Acids Res, 2011, 39(15): 6669-6678. 被引量:1

共引文献22

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部